Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by RAMP2 is a member of the RAMP family of single-transmembrane-domain proteins, called receptor (calcitonin) activity modifying proteins (RAMPs). Additionally we are shipping RAMP2 Proteins (9) and RAMP2 Kits (3) and many more products for this protein.
Showing 10 out of 60 products:
Human Polyclonal RAMP2 Primary Antibody for IF (p), IHC (p) - ABIN1386641
Qiao, Wang, Wang, Zhao, Zhang, Han, Peng: Intermedin is upregulated and attenuates renal fibrosis by inhibition of oxidative stress in rats with unilateral ureteral obstruction. in Nephrology (Carlton, Vic.) 2015
RAMP2 is essential for early vascular development and knockout-mice die in utero.
These results indicate the AM-RAMP2 system works to protect nerve cells from both acute and chronic cerebral ischemia by maintaining cerebral blood flow suppressing oxidative stress, and in the case of chronic ischemia, enhancing capillary growth.
The AM-RAMP2 system is a key determinant of vascular integrity and homeostasis from prenatal stages through adulthood.
These data demonstrate that the adrenomedullin (show ADM Antibodies)-RAMP2 system is essential for cardiac metabolism and homeostasis.
Data show that mechanical ventilation reduced the expression of receptor activity-modifying protein RAMP3 (show RAMP3 Antibodies), but not of intermedin (IMD (show ADM2 Antibodies)), calcitonin receptor-like receptor (CRLR (show CALCRL Antibodies)), and RAMP1 (show RAMP1 Antibodies) and RAMP2.
Adrenomedullin (show ADM Antibodies)-RAMP2 system is the potential target for the induction of liver sinusoidal endothelial cells.
this work reveals an essential role for RAMP2 in endocrine physiology and provides the first in vivo evidence for a physiological role of RAMP2 beyond that of AM/CLR (show CALCR Antibodies) signaling
role in cell surface expression of CRLR (show CALCRL Antibodies)/RAMP heterodimeric receptors
RAMP2 plays a key role in the sensitivity and potency of AM-induced hypotensive responses via the AM1 receptor.
RAMP2 and RAMP3 (show RAMP3 Antibodies) have distinct physiological functions throughout embryogenesis, adulthood, and old age
This study reveals the glucagon receptor (show GCGR Antibodies) as a previously unidentified target for GLP-1 receptor (show GLP1R Antibodies) agonists and highlights a role for RAMP2 in regulating its pharmacology.
Data suggest that ligand binding of a G protein-coupled receptor (GPCR (show TAS1R3 Antibodies)) may inform drug development targeting calcitonin receptor-like receptor (CLR (show CALCRL Antibodies)):receptor activity-modifying proteins RAMP1 (show RAMP1 Antibodies)/2 complexes.
the AM system is widely expressed in human thymus from newborns; both AM1 receptor components CLR (show DCLK3 Antibodies) and RAMP2, but not RAMP3 (show RAMP3 Antibodies), are not associated with the plasma membrane of TECs and thymocytes but are located intracellularly, notably in the nucleus
Adrenomedullin (show ADM Antibodies)-RAMP2 system suppresses ER stress-induced tubule cell death and is involved in kidney protection.
Data suggest isoforms of RAMP modulate accessibility of peptides to residues situated on CALCRL (calcitonin receptor-like receptor (show CALCRL Antibodies)) N-terminal domain; RAMP3 (show RAMP3 Antibodies)/RAMP2/RAMP1 (show RAMP1 Antibodies) appear to alter accessibility of specific residues at CALCRL (show CALCRL Antibodies)-RAMP interface.
RAMP2 gene expression increases with gestational age development in the fetal lung.
The CRLR (show CALCRL Antibodies)-RAMP2 interactions were confirmed for the full-length proteins on the cell surface by site-specific photo-crosslinking.
the hCRLR C-tail is crucial for adrenomedullin-evoked cAMP production and internalization of the CRLR/RAMP2, while the receptor internalization is dependent on the aforementioned GPCR kinases, but not Gs coupling.
results show the presence of calcitonin receptor-like receptor (show CALCRL Antibodies) and receptor activity-modifying proteins in middle meningeal, middle cerebral, pial, and superficial temporal vessels
Co-expression of calcitonin (show CALCA Antibodies) receptors (CT) lacking a portion of domain 1 with receptor activity-modifying protein (RAMP) 1 (show RAMP1 Antibodies), 2, or 3 appears to produce functional CT-(8 (show SYCP1 Antibodies)-32)-sensitive adrenomedullin (show ADM Antibodies) receptors.
Data indicate that adrenomedullin (show ADM Antibodies) mRNA and protein signal were only found in trophoblast binucleate cells (BNCs), whereas those of CRLR (show CALCRL Antibodies), RAMP2 and RAMP3 (show RAMP3 Antibodies) were detected in cotyledonary villous and caruncular epithelial cells.
The protein encoded by this gene is a member of the RAMP family of single-transmembrane-domain proteins, called receptor (calcitonin) activity modifying proteins (RAMPs). RAMPs are type I transmembrane proteins with an extracellular N terminus and a cytoplasmic C terminus. RAMPs are required to transport calcitonin-receptor-like receptor (CRLR) to the plasma membrane. CRLR, a receptor with seven transmembrane domains, can function as either a calcitonin-gene-related peptide (CGRP) receptor or an adrenomedullin receptor, depending on which members of the RAMP family are expressed. In the presence of this (RAMP2) protein, CRLR functions as an adrenomedullin receptor. The RAMP2 protein is involved in core glycosylation and transportation of adrenomedullin receptor to the cell surface.
receptor (calcitonin) activity modifying protein 2
, receptor activity modifying protein 2
, receptor activity-modifying protein 2
, receptor (G protein-coupled) activity modifying protein 2
, receptor activity modifying protein 2 isoform
, CRLR activity-modifying protein 2
, calcitonin receptor-like receptor activity modifying protein 2
, calcitonin-receptor-like receptor activity-modifying protein 2
, receptor-activity-modifying protein 2